AI glasses mark a third optical-retail era, shifting power to consumer/technology pull and risking optician commoditisation, though fitting and trust remain advantages; profit capture may accrue to platforms and vertically integrated eyewear giants.

Extending the Stellantis tie-up from manufacturing into joint vehicle development lets Tata Motors use more of its own engineering in cars sold across 50+ markets while sharing platform costs.

Pioneer of the inverter welder (first 100kHz), but its pricing power is eroding as local Chinese clones undercut it; revenue slid to ~$125mn and net profit fell ~30% on margin compression.

India competes on assembly and labour while China owns the component ecosystem (IGBTs, boards, capacitors), so India imports the value-added guts and cannot out-cheap a rival that makes the parts next door.

The scaled commercialiser of cheap inverter welding, now squeezed by the same copycats it spawned, with net profit down over 20%; betting on handheld fibre laser welders to repeat the arc-welder commoditisation.

India consumes vast volumes of IGBT power chips in solar inverters and EV traction but makes almost none, leaving grid and mobility supply exposed to China; Semiconductor Mission spending targets logic and packaging, not power/compound semis.

Market treats Time Technoplast as a plastic drum maker, but it controls ~90% of India's IBC market and is shifting toward higher-margin composite cylinders, giving a large global conversion runway. The drum cash cow funds a higher-value business the market may be mispricing.

Tonbo has genuine thermal-imaging technology, a strong Indian Army franchise, and fast-growing platform systems, but its IPO is a 100% offer for sale, leaving proceeds to selling entities while tactical EO/IR growth slows and orders are episodic.

Fairfax's ₹53,000 crore deal for a 60.72% controlling stake could complete IDBI's decade-long turnaround, though the transaction remains subject to stringent RBI ownership and voting-rights rules.

Cheap Chinese sterile fill-finish lines enable India's semaglutide price war and faster biosimilar scale-up, but deepen dependence: India owns neither its drug ingredients nor the machines making its medicines.

Truking bought Germany's Romaco to gain European GMP credibility and sell German-designed equipment at Chinese cost; but domestic sales fell ~7% in 9M 2025 with only ~$13mn profit.

China's 2010 GMP mandate built Tofflon into a low-cost fill-finish equipment maker undercutting Europe by 40-50%; it is now exporting hard, but a domestic price war cut 2024 revenue ~11%.

S J Logistics is forward-integrating from freight forwarding and NVOCC into chartered vessel operations through a Dubai JV, which can drive scalable growth; low valuation offers upside if execution holds, though earnings become more freight-rate cyclical and fixed-cost heavy.

Forward integration from freight forwarding/NVOCC into chartered container vessel operations on India–Gulf–Mediterranean routes should support scalable growth, aided by its existing cargo network and JV with Nexus Line.

Hengli built a hydraulic-muscle moat via in-house castings and pumps/valves, supplies Caterpillar, and is pivoting to planetary roller screws for robots, but margin squeeze and founder detention add risk.

India lacks a domestic high-pressure hydraulics/precision-component champion like Hengli, so its machinery and robotics ambitions rely on Chinese parts; the gap may widen as Hengli integrates roller screws.

Indian auto sector has long growth runway from low car penetration (33/1,000), rising GDP per capita, premiumisation toward SUVs, and government EV push; the sector is a key beneficiary.

India's fast-growing data centre buildout will hit the same thermal wall, but with no domestic full-chain cooling champion the AI stack's thermal layer risks becoming a strategic import absent a PUE mandate.

Envicool owns the entire liquid-cooling chain in-house, letting it undercut Vertiv and Schneider on price while China's PUE mandate hands it captive demand, making it the pick-and-shovel play on AI heat.

Sovereign cloud and AI infra provider whose profits are projected to jump from ₹121 cr in FY26 to ₹400 cr in FY27 and ₹700 cr in FY28, driven mainly by the USD 1.25 bn Sharon AI GPU deal.

ESDS is a sovereign cloud/AI infrastructure play; its ~USD1.25bn Sharon AI GPU contract should drive profits from ₹121cr in FY26 to ₹400cr in FY27 and ₹700cr in FY28.

Pure-play B2B maker of heavy tubular wind turbine towers with a 493 Cr orderbook versus 143 Cr prior-year revenue, new Gujarat plant coming online, and IPO-funded debt repayment, positioning it to roughly double revenue and PAT with large order wins as a catalyst.

Pure-play wind turbine tower maker with dual-state plants, strong order book, IPO debt repayment, and high ROE; poised to double revenue and PAT, with large order wins as a catalyst.

Zetwerk’s tech-led contract manufacturing model has scaled revenue, but thin 2.65% adjusted EBITDA margins and persistent working-capital cash outflows mean order growth must convert to cash to break its debt cycle.

Cost-leading Chinese metal 3D printer maker whose vertical integration (domestic lasers, in-house titanium powder, multi-laser software) plus surging consumer-electronics demand, notably Apple Watch titanium parts, drove a sharp 2025 profit rebound after a 2024 margin collapse.

Open-architecture Chinese printer maker that doubled laser count to 32 and has sold 150-plus metre-scale metal systems globally, pressing the West on price and capability.

Pure-play wind turbine tower maker with 493 Cr orderbook vs 143 Cr FY26 revenue, new Gujarat plant and in-house value addition should drive revenue and PAT to roughly double by FY27, with large order wins as a catalyst.

India’s EV push lacks domestic high-voltage DC contactor production, leaving a Chinese import dependency in safety-critical circuits; component depth in ceramics and metallurgy is the missing durable industrial moat.

Profitable Tier-II auto plastic parts maker in Tata's Sanand vendor park with structural proximity advantage, strong cash conversion and a funded 44% capacity expansion driving ~26% revenue and PAT growth into FY28 at a cheap 9x earnings.

Profitable Tier-II auto-component maker in the Sanand vendor park with high ROCE and strong cash conversion; IPO funds Plant II capacity expansion, offering growth at about 9x diluted earnings despite high customer concentration.

Huge capex in forging, machining and defence (artillery shells, NATO/aerospace orders) should drive a mid-term earnings spurt and re-rating, but weak management, IT search and working-capital issues make it a trading bet, not a long-term hold.

Fire-hit Rajkot plant is live, capacity is 50% higher, backward integration and Mumbai facility cut costs; distributor expansion and high-margin products should lift revenue and EBITDA margins to 11-12%, with worst behind.

Equipment makers' competitiveness now hinges on productivity, yield and manufacturing cost rather than technology alone, so investors should track actual production adoption, orders and cost-per-good-chip economics instead of technology headlines.

US PERM freeze poses limited risk to Indian IT firms, which have already cut H-1B/PERM reliance via offshoring and US local hiring; the policy hits Microsoft and Big Tech harder.

Fast-rising number-three optical-module maker with doubled revenue and 48% gross margins, helped by silicon-photonics acquisition, but thin operating cash versus booked profit raises earnings-quality questions.

World's largest optical-module maker with over half of Nvidia's 800G supply, riding explosive AI datacentre demand, but faces long-term risk as co-packaged optics shift value back to chip designers and US bans loom.

India's ~₹10.4k crore IndiaAI compute push depends on imported optical modules it does not make, most likely from Chinese firms the US is trying to ban, exposing it to price and allocation whipsaw while offering a scalable manufacturing opportunity.

CleanMax exploits India’s C&I power tariff arbitrage via group-captive and virtual PPA renewable sales, with hyperscaler/AI data-centre demand, grid-connectivity pipeline and sticky 25-year contracts driving durable growth.

AI GPU demand may grow, but E2E's investment case is uncertain because costly hardware and rising competition could weaken rental pricing and cash returns on capital.

India is subsidising farm-drone demand through Namo Drone Didi far faster than it can build hardware, so the scheme risks funding demand that only Chinese supply chains can profitably serve until an Indian player closes the cost gap.

XAG turned farm spraying into cheap farm robotics by riding China's commoditised supply chain, cut drone prices to ~$5,300, swung to profit and now exports deflation via dealer tie-ups; the bet is thin-margin hardware scale plus chemistry lock-in.

Herd behavior drove quality compounders to 40-50x P/E, leaving no margin of safety; when growth narratives break these stocks fall 50-80% and sit in an 'air pocket' — too growthy for value buyers, still too expensive for value investors.

Cited as the author's own mistake of holding a great business too long at a high multiple, illustrating that 40-50x P/E quality names should generally be sold rather than held through hiccups.

LAB realisations doubled to ~$2,400/t, anti-dumping duties and capacity expansions support record FY27 revenue/PAT, while the stock trades at 4-5x FY27 earnings and 0.3x sales, implying 70-100% upside.

TPL's LAB realizations doubled, anti-dumping protection and tight global supply plus expanded capacity could drive record FY27 revenue/PAT; stock trades cheap at 4-5x FY27 PE and 0.3x sales, offering 70-100% upside if execution delivers.

New ₹84,084-crore Samudra Manthan scheme plus 2025 oilfield reforms subsidise up to half of deepwater drilling costs and shared infrastructure, de-risking offshore exploration and reviving interest in India's undrilled basins — though output is not expected before the 2030s.

India lacks commercial nonlinear-crystal and gallium/germanium refining capacity, making its laser, photonics, EV, solar and semiconductor industries dependent on Chinese chokepoints; building local lab-to-scale materials capability is a strategic long-term need.

A global leader in specialty chemical chains with a deep, 40-year integration moat, but profit has fallen for five years despite doubling revenue; the next two years decide whether its built fortress finally converts to cash.

Well-run, conservatively managed NBFC lending to MSMEs with a fully secured, self-sourced book growing ~33% CAGR, high ~17% yields, ~4.5% RoA and rising ~13% RoE — though low PCR and untested portfolio seasoning bear watching.

SBFC Finance is a well-run, fast-growing NBFC with a secured, self-sourced loan book, high ROA/ROE, and strong management, though low PCR and unseasoned portfolio pose risks.